CoChat

Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms

Open access
Fernández-Billón, María, Llambías-Cabot, Aina E., Jordana-Lluch, Elena, Oliver, Antonio, Macià, María D. · 2023 · Biofilm

The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index; none of the 131 sources its claims cite is checked for support yet.

Abstract

Pseudomonas aeruginosa is a major cause of life-threatening acute infections and life-long lasting chronic infections. The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance, involving physical and physiological factors in addition to biofilm-specific genes that can confer a transient protection against antibiotics promoting the development of resistance. Indeed, a striking feature of this pathogen is the extraordinary capacity to develop resistance to nearly all available antibiotics through the selection of chromosomal mutations, evidenced by its outstanding and versatile mutational resistome. This threat is dramatically amplified in chronic infections, driven by the frequent emergence of mutator variants with enhanced spontaneous mutation rates. Thus, this mini review is focused on describing the complex interplay of antibiotic resistance mechanisms in P. aeruginosa biofilms, to provide potentially useful information for the design of effective therapeutic strategies.

Overview

CoChat Summary

TL;DR

This mini-review describes how *Pseudomonas aeruginosa* biofilms combine transient antibiotic tolerance mechanisms with conventional resistance mechanisms, including mutational resistance and horizontal gene transfer. It argues that biofilm physiology and population structure create a favorable environment for resistance emergence and discusses therapeutic strategies targeting biofilm-specific vulnerabilities.

Key findings

  • Biofilm tolerance involves matrix binding/penetration delay, nutrient and oxygen gradients, low metabolic activity, persisters (<0.1% of the biofilm population), reduced ROS, upregulated efflux pumps, and adaptive responses such as colistin-induced *pmr*/*arn* and β-lactam-induced AmpC; these confer transient protection rather than conventional resistance.
  • Conventional resistance in biofilms includes mutational resistance and horizontal gene transfer. Mutator/hypermutable strains are present in over one-third of studied cystic fibrosis patients with chronic respiratory infections, compared with 10% at chronic infection onset, 6% in the environment, and <1% in acute infections.
  • Biofilm-specific gene expression contributes to resistance: *brlR* activates MexAB-oprM and MexEF-oprN efflux pumps and the ABC transporter PA1874-1877 (10 times more expressed in biofilms), and increased *brlR* lowered susceptibility to hydrogen peroxide and five different classes of antibiotics, increasing MICs up to 6-fold.
  • Biofilms facilitate horizontal gene transfer via conjugation, transformation, and transduction; conjugation occurs at higher frequencies than in planktonic cultures, and biofilms can act as plasmid reserves preserving multidrug-resistance plasmids. Mixed biofilm communities also show shielding, e.g., PAO1Δ*dacB* resistant mutants were selected for and amplified under cefepime and located in outer biofilm layers surrounding sensitive PAO1.

Methods

  • Design: narrative mini-review; no primary experiments or systematic review methodology are reported.
  • Data or sample: published literature on *P. aeruginosa* biofilms, antibiotic tolerance/resistance mechanisms, and related in vitro, in vivo, and cystic fibrosis clinical studies; no new sample or dataset is generated.
  • Main analysis: synthesis of cited studies and mechanisms, including a figure adapted from Ciofu et al., *Nat Rev*, 2022.

Limitations

  • The paper states no limitations.
  • Evident: as a mini-review, it lacks systematic search/selection criteria and does not report primary data or quantitative synthesis.
  • Evident: its scope is restricted to *P. aeruginosa* biofilms and antibiotic resistance/tolerance mechanisms; the therapeutic strategies discussed are not clinically validated in this paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.bioflm.2023.100129

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Mechanisms of antimicrobial tolerance and resistance found in biofilms and antibiotics affected by them. FQ: Fluoroquinolones; AMG: Aminoglycosides; AZT: Azitromycin; LPS: lipopolysaccharide. Figure adapted from Ciofu O et al., Nat rev, 2022 [62].
Fig. 1 Mechanisms of antimicrobial tolerance and resistance found in biofilms and antibiotics affected by them. FQ: Fluoroquinolones; AMG: Aminoglycosides; AZT: Azitromycin; LPS: lipopolysaccharide. Figure adapted from Ciofu O et al., Nat rev, 2022 [62].CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 3 Not valid · 75 Not checked · 10 Own results and interpretations

48 more claims

Create a free account to see all 88 claims and to verify the 131 references still open.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Citations

Cites

Cited by

See all 170

Metadata

Authors
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D.
Affiliations
Instituto de Salud Carlos III (ES)
Venue
Biofilm
Publisher
Elsevier BV
Published
2023-12
Volume
5
Pages
100129
ISSN
2590-2075 (ISSN-L)
OpenAlex
W4367693161
Cited by
170
References
136
Citations by year
2026: 65 · 2025: 64 · 2024: 34 · 2023: 7
FWCI
11.48
Type
journal article
Language
en
Open access
Licence
Locations
  • Biofilm (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Hispana (submittedVersion, cc-by-nc-nd)
Funders
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia e Innovación
  • Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (2322/2746)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
Pseudomonas aeruginosa, biofilm, antibiotic resistance, spontaneous mutation rate, chronic infection, chronic lung infection, antimicrobial therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.